WallStreetZenWallStreetZen

NASDAQ: CTY
City Therapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
City Therapeutics revenue was N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CTY annual revenue was $13.6M, with 388.2% growth year-over-year.

CTY revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when CTY announces revenue.

CTY Revenue History By Year

CTY Yearly RevenueCTY RevenueCTY ChangeCTY Revenue Growth
2025-12-31$13.56M$10.78M+388.19%
2024-12-31$2.78MN/AN/A

1 of 1

City Therapeutics Revenue FAQ

What was City Therapeutics's annual revenue growth in the past year?

As of Q4 2026, City Therapeutics's revenue has grown null year over year. City Therapeutics's revenue in the past year totaled N/A.

How much does City Therapeutics make in a year?

City Therapeutics's revenue by year for the past one years is:
  • City Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $13.56 million, a 388.19% increase year over year.

What was City Therapeutics's revenue in 2025?

City Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $13.56 million, a 388.19% increase year over year.

How much does City Therapeutics make in a day?

Based on City Therapeutics annual revenue for the past one years, CTY makes an average of $37,156.16 per day.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.